Identification of HER2-positive breast carcinomas as a particular subset with peculiar clinical behaviours
Main Authors: | Casalini, P, Ménard, S, Balsari, A, Tagliabue, E, Campiglio, M, Bufalino, R, Cascinelli, N |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2001
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300523/ |
Similar Items
-
Rescue of HER-2-positive breast carcinoma cells from dormancy by growth factors produced during wound healing
by: Agresti, R, et al.
Published: (2001) -
“Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas
by: Tagliabue, Elda, et al.
Published: (2014) -
Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.
by: Tagliabue, E., et al.
Published: (1996) -
Prognosis based on primary breast carcinoma instead of pathological nodal status.
by: Ménard, S., et al.
Published: (1994) -
Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors
by: Lucci, Maria Antonietta, et al.
Published: (2010)